Clinical Trial Update: 3T MRI Biomarkers of Glioma Treatment Response [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating 3T MRI biomarkers for glioma treatment response, sponsored by Vanderbilt-Ingram Cancer Center, has been terminated. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Anaplastic Oligodendroglioma
• Brain Neoplasm
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | EARLY_Phase 1 | Status: TERMINATED